http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013059823-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cb63a50f7902e2961dfef13a70884fff http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cc63776af551c44295a3a54fc8b86a17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9dad2d60c422e966f81bd27c05947631 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8ee8a883387a7bab74b3395bcb99c987 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-14 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C291-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B59-001 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C245-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-655 |
| filingDate | 2011-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ef842fe4db878e681f9b1ef46e5ff69 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7eec16725651d9547ecef06cde7424a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a5417cf09f22e0d96fa01cbb5c1139b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88abe7f8247589f333c1a40c66c903eb |
| publicationDate | 2013-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2013059823-A1 |
| titleOfInvention | Diazeniumdiolate Cyclohexyl Derivatives |
| abstract | A compound having the structure (I) or a pharmaceutically acceptable salt thereof, wherein R 3 is hydrogen, deuterium, —OH, —OC 1-6 alkyl, or halogen; R 8 is hydrogen, deuterium, or C 1-6 alkyl; R 11 and R 12 are independently hydrogen, —C 1-6 alkyl, —OH, —OC 1-6 alkyl, or halogen; R 13 and R 14 are independently —C 1-6 alkyl, —(CH 2 ) 1-2 OH, or —OC 1-6 alkyl, or, together with the nitrogen atom to which they are attached, form a 4 - to 7 -membered heterocyclic ring containing one nitrogen atom and 0 or 1 oxygen atoms, wherein said ring is unsubstituted or mono-, di- or tri-substituted with halogen or —C 1-6 alkyl; R 15 is (CR 1 R 2 ) n C(O)OR 16 , wherein n is 0, 1 or 2 , —C(O)NHCH(R 17 )OR 16 , or —C(O)NHCH(R 17 )C(O)NHCH(R 18 )C(O)OR 16 ; R 16 is hydrogen, C 1-6 alkyl, or (CH 2 ) 1-2 N+R 19 R 20 R 21 ; R 1 , R 2 , R 4 , R 5 , R 6 , R 7 , R 9 , R 10 , R 17 , R 18 , R 19 , R 20 , and R 21 are independently hydrogen or —C 1-6 alkyl; and stereoisomers thereof, and pharmaceutically acceptable salts thereof, and pharmaceutically acceptable salts of stereoisomers thereof. |
| priorityDate | 2010-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 986.